IUI vs. IVF/ICSI in Women Aged 38-42 Years: a Prospective Randomized Controlled Trial.
NCT01992731 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 138
Last updated 2015-03-27
Summary
Prospective randomised controlled trial: 3 IUI cycles versus 1 IVF/ICSI cycle in women aged 38-42 years.
Conditions
Interventions
- OTHER
-
Drug: Follitropine Bèta
Sponsors & Collaborators
-
Universitair Ziekenhuis Brussel
lead OTHER
Principal Investigators
-
Michael De Brucker, MD · Universitair Ziekenhuis Brussel
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 38 Years
- Max Age
- 42 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-12-31
- Primary Completion
- 2016-12-31
- Completion
- 2017-03-31
Countries
- Belgium
Study Locations
More Related Trials
-
Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Classical Antagonist Protocol
NCT03684421 ·Status: UNKNOWN
-
IUI With Letrozole Versus in Natural Cycle
NCT04169451 ·Status: RECRUITING ·Phase: NA
-
Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation
NCT01044862 ·Status: COMPLETED ·Phase: PHASE3
-
Intrauterine Insemination With Letrozole Versus in Natural Cycle
NCT03455426 ·Status: COMPLETED ·Phase: NA
-
Frozen Embryo Transfer (FET) in Natural Cycles or in Natural Cycles Controlled by Human Chorionic Gonadotropin (hCG) Administration
NCT00809107 ·Status: COMPLETED ·Phase: NA
-
Intrauterine Injection of HCG and Implantation Rate
NCT01933126 ·Status: UNKNOWN ·Phase: NA
-
Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF)
NCT00827983 ·Status: COMPLETED ·Phase: PHASE3
-
The Value of Progesterone for the Timing of the Embryo Transfer in IVF/ICSI: a Prospective Randomised Trial
NCT03162315 ·Status: COMPLETED ·Phase: NA
-
Vaginal Versus Combined Use of Progesterone in Fresh IVF/ICSI Cycles
NCT05089383 ·Status: UNKNOWN
-
Effect Of Intravenous IntralipidTherapyon Pregnancy Outcome in Women With History of Recurrent Implantation Failure Undergoing Intracytoplasmic Sperm Injection-Embryo Transfer Cycle: A Randomized Controlled Trial
NCT03374163 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Long Agonist Protocol
NCT03693534 ·Status: UNKNOWN
-
Timing and Intrauterine Insemination in Unexplained Infertility
NCT03920514 ·Status: UNKNOWN ·Phase: PHASE4
-
Natural Versus Artificial Cycle for Frozen-Thawed Embryo Transfer
NCT03642665 ·Status: COMPLETED ·Phase: PHASE4
-
Stimulated Intrauterine Insemination Cycles and Unstimulated Intrauterine Insemination Cycles in Couples With Unexplained Infertility
NCT02461173 ·Status: UNKNOWN ·Phase: PHASE3
-
Intrauterine Insemination and Luteal Fase Support
NCT01826747 ·Status: COMPLETED ·Phase: PHASE4
-
Luteal Phase Support With GnRH Agonist After GnRH Agonist Triggering in IVF/ICSI Cycles
NCT06150703 ·Status: RECRUITING ·Phase: PHASE3
-
Gynecologists' Feedback on ART-Birth Rates
NCT04169295 ·Status: COMPLETED ·Phase: NA
-
Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders
NCT04487925 ·Status: RECRUITING ·Phase: PHASE4
-
Luteal Support and Intrauterine Insemination (IUI) With Clomiphene Citrate
NCT01046708 ·Status: COMPLETED ·Phase: NA
-
Intrauterine Injection of Human Chorionic Gonadotrophin and Pregnancy Rate in ICSI
NCT03445910 ·Status: COMPLETED ·Phase: NA
-
Role of Heparin in Poor Responders Undergoing In Vitro Fertilisation
NCT01315093 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Difference Between Progestin Primed Ovarian Stimulation Protocol and Antagonist Protocol
NCT06738602 ·Status: NOT_YET_RECRUITING
-
Comparison of Recombinant Follicle Stimulating Hormone and the Combination of Recombinant Follicle Stimulating Hormone With Clomiphene Citrate in Stimulated Intrauterine Insemination Cycles
NCT05670795 ·Status: RECRUITING ·Phase: NA
-
Different Strategies in Frozen IVF/ICSI Cycles
NCT03965949 ·Status: COMPLETED
-
A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment
NCT02309671 ·Status: COMPLETED ·Phase: PHASE2